RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole
Released: Wednesday 8th June 2022
Edinburgh, UK, 08 June 2022 – RoslinCT - a cell and gene therapy/ATMP CDMO, developing life-changing cell and gene therapies in Edinburgh’s BioQuarter– signs lease for 1,453 sqm additional space at Charles Darwin House at the Edinburgh Technopole.
For full details please click here.
